• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

IV - Articles and news items

FDA grants QIDP for C. Difficile IV treatment

Industry news / 25 July 2016 / Niamh Louise Marriott, Digital Content Producer

Morphochem announced today that the U.S. FDA has designated Morphochem’s intravenous antibacterial product as a Qualified Infectious Disease Product…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +